Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18510 | 483 | 29.6 | 44% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3498 | 1020 | SILDENAFIL ANALOGUE//COUNTERFEIT MEDICINES//SUBSTANDARD DRUGS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SUBSTANDARD DRUGS | Author keyword | 18 | 83% | 2% | 10 |
2 | ONLINE PHARMACIES | Author keyword | 13 | 71% | 2% | 10 |
3 | ONLINE PHARMACY | Author keyword | 12 | 86% | 1% | 6 |
4 | PROMOTING QUAL MED PROGRAM | Address | 11 | 100% | 1% | 6 |
5 | GRIPE GRP INVESTIGADOR PROBLEMAS ENFERMEDADES INF | Address | 9 | 83% | 1% | 5 |
6 | INTERNET PHARMACY | Author keyword | 8 | 70% | 1% | 7 |
7 | SUBSTANDARD | Author keyword | 8 | 62% | 2% | 8 |
8 | DRUG QUALITY | Author keyword | 7 | 41% | 3% | 14 |
9 | SAN DIEGO PATIENT SAFETY | Address | 7 | 34% | 4% | 17 |
10 | JOINT DOCTORAL PROGRAM GLOBAL HLTH | Address | 7 | 46% | 2% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SUBSTANDARD DRUGS | 18 | 83% | 2% | 10 | Search SUBSTANDARD+DRUGS | Search SUBSTANDARD+DRUGS |
2 | ONLINE PHARMACIES | 13 | 71% | 2% | 10 | Search ONLINE+PHARMACIES | Search ONLINE+PHARMACIES |
3 | ONLINE PHARMACY | 12 | 86% | 1% | 6 | Search ONLINE+PHARMACY | Search ONLINE+PHARMACY |
4 | INTERNET PHARMACY | 8 | 70% | 1% | 7 | Search INTERNET+PHARMACY | Search INTERNET+PHARMACY |
5 | SUBSTANDARD | 8 | 62% | 2% | 8 | Search SUBSTANDARD | Search SUBSTANDARD |
6 | DRUG QUALITY | 7 | 41% | 3% | 14 | Search DRUG+QUALITY | Search DRUG+QUALITY |
7 | FALSIFIED | 6 | 80% | 1% | 4 | Search FALSIFIED | Search FALSIFIED |
8 | INTERNET PHARMACIES | 6 | 80% | 1% | 4 | Search INTERNET+PHARMACIES | Search INTERNET+PHARMACIES |
9 | COUNTERFEIT DRUGS | 5 | 29% | 3% | 14 | Search COUNTERFEIT+DRUGS | Search COUNTERFEIT+DRUGS |
10 | SUBSTANDARD MEDICINES | 4 | 75% | 1% | 3 | Search SUBSTANDARD+MEDICINES | Search SUBSTANDARD+MEDICINES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FAKE ARTESUNATE | 38 | 86% | 4% | 19 |
2 | COUNTERFEIT | 33 | 67% | 6% | 30 |
3 | SUBSTANDARD MEDICINES | 18 | 83% | 2% | 10 |
4 | SUBSTANDARD DRUGS | 15 | 77% | 2% | 10 |
5 | COUNTERFEIT DRUGS | 10 | 61% | 2% | 11 |
6 | COUNTERFEIT ANTIMALARIAL TABLETS | 8 | 75% | 1% | 6 |
7 | SULPHADOXINE PYRIMETHAMINE TABLETS SOLD | 8 | 100% | 1% | 5 |
8 | DRUG QUALITY | 7 | 67% | 1% | 6 |
9 | ANTIMALARIAL DRUG QUALITY | 6 | 71% | 1% | 5 |
10 | ARTESUNATE ANTIMALARIAL TABLETS | 5 | 63% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa | 2012 | 74 | 37 | 70% |
Substandard and counterfeit medicines: a systematic review of the literature | 2013 | 20 | 16 | 88% |
Counterfeit anti-infective drugs | 2006 | 113 | 43 | 49% |
Understanding and fighting the medicine counterfeit market | 2014 | 12 | 49 | 33% |
Update on counterfeit antibiotics worldwide; Public health risks | 2012 | 10 | 2 | 100% |
Substandard medicines in resource-poor settings: a problem that can no longer be ignored | 2008 | 74 | 21 | 57% |
Quality of Online Pharmacies and Websites Selling Prescription Drugs: A Systematic Review | 2011 | 16 | 66 | 62% |
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks | 2010 | 27 | 12 | 67% |
Substandard/Counterfeit Antimicrobial Drugs | 2015 | 1 | 92 | 61% |
Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence | 2007 | 61 | 68 | 51% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROMOTING QUAL MED PROGRAM | 11 | 100% | 1.2% | 6 |
2 | GRIPE GRP INVESTIGADOR PROBLEMAS ENFERMEDADES INF | 9 | 83% | 1.0% | 5 |
3 | SAN DIEGO PATIENT SAFETY | 7 | 34% | 3.5% | 17 |
4 | JOINT DOCTORAL PROGRAM GLOBAL HLTH | 7 | 46% | 2.3% | 11 |
5 | JOINT DOCTORAL PROGRAM GLOBAL PUBL HLTH | 6 | 80% | 0.8% | 4 |
6 | DRUGS FOOD | 6 | 100% | 0.8% | 4 |
7 | HLTH PROD QUAL CONTROL | 6 | 100% | 0.8% | 4 |
8 | HLTH LAW STUDIES | 5 | 28% | 3.1% | 15 |
9 | QUAL TECHNOL ASSESSMENT GOVERNANCE COMMUN STR | 3 | 57% | 0.8% | 4 |
10 | SECT HYG EPIDEMIOL PUBL HLTH | 3 | 42% | 1.0% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000211765 | SILDENAFIL ANALOGUE//TADALAFIL ANALOGUE//HOMOSILDENAFIL |
2 | 0.0000103769 | DIRECT TO CONSUMER ADVERTISING//DTCA//DTC ADVERTISING |
3 | 0.0000087619 | MALARIA CHILD SURVIVAL//KNOWLEDGE MANAGEMENT IMPLEMENTAT UNIT//PATENT MEDICINE VENDORS |
4 | 0.0000059720 | PHARMACEUTICAL ASSISTANCE//JUDICIAL DECISIONS//NATIONAL POLICY OF PHARMACEUTICAL ASSISTANCE |
5 | 0.0000058637 | DRUG STABILITY STUDY//EXPIRATION DATING PERIOD//BRACKETING DESIGN |
6 | 0.0000052438 | BLEND UNIFORMITY//PROCESS ANALYTICAL TECHNOLOGY//CONTENT UNIFORMITY |
7 | 0.0000051306 | DISCOVERY ANALYT CHEM CHEM TECHNOL//LC MS TECHNOL DEV//SHANGHAI MASS SPE OMETRY |
8 | 0.0000050494 | DRUG SHORTAGES//VACCINE STOCKPILES//VACCINE SHORTAGE |
9 | 0.0000047966 | PHARMACEUTICAL COATING//2 DIOL COPOLYESTER//AQUEOUS ENTERIC COATING |
10 | 0.0000047523 | GENERIC SUBSTITUTION//GENERIC DRUGS//REFERENCE PRICING |